Don’t miss this opportunity to hear from industry leaders shaping the future of resilient and sustainable supply chains

Tackling Scope 3 emissions – those indirect emissions that occur in a company’s value chain – is one of the greatest sustainability challenges facing the pharmaceutical sector. No single company can achieve Net-Zero targets alone. This panel explores how cross-industry collaboration, data transparency, and the right technology partners are helping pharma make real progress.

• How companies are overcoming barriers to sharing Scope 3 emissions data with suppliers and partners.
• Strategies for getting suppliers aligned on decarbonisation goals and reporting standards.
• A spotlight on tools like Manufacture 2030 and how they are enabling scalable, verified emissions tracking and reduction efforts.

Speakers

• Sushree Mishra, Head - Global Corporate Strategy, Corporate Communications & Inlicensing, JB Pharma
• Peylina Chu, Chair, Steering Committee, CPHI Sustainability Collective
• Ines Windisch, Head of Corporate Affairs & Sustainability, Zentiva
• Sandra Matamoros, Global Program Lead Responsible Sourcing, Grunenthal Pharma & CO KG
• Darryl Ratty, Executive Director, Global ESG, SK pharmteco

Panel Details
Panel: Collective Action, Real Results: The Power of Partnership on Scope 3 Emissions
Date: Tuesday, October 28, 2025
Time: 11:35 AM to 12:20 PM (CET)
Location: Hall 4 - 4.0G36, CPHI Frankfurt

Find out more information here.